![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Karger
E-ISSN: 1421-9794|58|1|30-33
ISSN: 0009-3157
Source: Chemotherapy, Vol.58, Iss.1, 2012-02, pp. : 30-33
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chemotherapy, Vol. 58, Iss. 2, 2012-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Chemotherapy, Vol. 62, Iss. 5, 2017-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/o.png)
![](/images/ico/ico5.png)
By Liu Jing Chen Zhiyu Chen Hanmei Hou Yingyong Lu Weiqi He Junyi Tong Hanxing Zhou Yuhong Cai Weimin
International Journal of Molecular Sciences, Vol. 18, Iss. 3, 2017-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
A Phase I Trial of Sunitinib and Rapamycin in Patients with Advanced Non-Small Cell Lung Cancer
Chemotherapy, Vol. 59, Iss. 1, 2013-04 ,pp. :